Vistagen Therapeutics, Inc. (VTGN)

Vistagen Therapeutics Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Vistagen Therapeutics stock has a target of 0.90, which predicts a 32.72% increase from the current stock price of 0.68.

Price Target: $0.90 (+32.72%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	$0.90	$0.90	$0.90	$0.90
Change	+32.72%	+32.72%	+32.72%	+32.72%

Analyst Ratings

The average analyst rating for Vistagen Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	3	3	3	3	3	0
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Tim Lugo William Blair	William Blair	Buy → Hold Downgrades n/a	Buy → Hold	Downgrades	n/a	n/a	Dec 17, 2025
Jason McCarthy Maxim Group	Maxim Group	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Dec 17, 2025
Andrew Tsai Jefferies	Jefferies	Strong Buy → Hold Downgrades $15 → $0.9	Strong Buy → Hold	Downgrades	$15 → $0.9	+32.72%	Dec 17, 2025
Andrew Tsai Jefferies	Jefferies	Hold → Strong Buy Upgrades $0.2 → $15	Hold → Strong Buy	Upgrades	$0.2 → $15	+2,112.06%	Dec 7, 2023
Paul Matteis Stifel	Stifel	Strong Buy Initiates $12	Strong Buy	Initiates	$12	+1,669.65%	Nov 14, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

749.70K

Increased by 54.26%

from 486.00K

Revenue Next Year

4.34M

Increased by 478.23%

from 749.70K

EPS This Year

-1.85

from -1.67

EPS Next Year

-1.33

from -1.85

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2021	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	1.09M	1.11M	-227.00K	1.06M	486.00K	749.70K	4.34M
Revenue Growth	-	1.78%	-	-	-54.32%	54.26%	478.23%
EPS	-14.74	-7.38	-8.51	-1.52	-1.67	-1.85	-1.33
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	7	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	1.5M	8.9M
Avg	749,700	4.3M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	211.1%	1,090.5%
Avg	54.3%	478.2%
Low	-	-

EPS Forecast

EPS	2026	2027	2028	2029	2030
High	-1.55	-0.87
Avg	-1.85	-1.33
Low	-2.03	-1.66

EPS Growth

EPS Growth	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.